526 related articles for article (PubMed ID: 27718416)
1. When pathological and radiological correlation is achieved, excision of fibroadenoma with lobular neoplasia on core biopsy is not warranted.
Fives C; O'Neill CJ; Murphy R; Corrigan MA; O'Sullivan MJ; Feeley L; Bennett MW; O'Connell F; Browne TJ
Breast; 2016 Dec; 30():125-129. PubMed ID: 27718416
[TBL] [Abstract][Full Text] [Related]
2. Follow-up surgical excision is indicated when breast core needle biopsies show atypical lobular hyperplasia or lobular carcinoma in situ: a correlative study of 33 patients with review of the literature.
Elsheikh TM; Silverman JF
Am J Surg Pathol; 2005 Apr; 29(4):534-43. PubMed ID: 15767810
[TBL] [Abstract][Full Text] [Related]
3. Surgical Outcomes of Lobular Neoplasia Diagnosed in Core Biopsy: Prospective Study of 316 Cases.
Susnik B; Day D; Abeln E; Bowman T; Krueger J; Swenson KK; Tsai ML; Bretzke ML; Lillemoe TJ
Clin Breast Cancer; 2016 Dec; 16(6):507-513. PubMed ID: 27425222
[TBL] [Abstract][Full Text] [Related]
4. Long term clinical follow-up of atypical ductal hyperplasia and lobular carcinoma in situ in breast core needle biopsies.
Renshaw AA; Gould EW
Pathology; 2016 Jan; 48(1):25-9. PubMed ID: 27020205
[TBL] [Abstract][Full Text] [Related]
5. The significance of lobular carcinoma in situ and atypical lobular hyperplasia of the breast.
Lewis JL; Lee DY; Tartter PI
Ann Surg Oncol; 2012 Dec; 19(13):4124-8. PubMed ID: 22847126
[TBL] [Abstract][Full Text] [Related]
6. Atypical lobular hyperplasia or lobular carcinoma in situ at core-needle breast biopsy.
Berg WA; Mrose HE; Ioffe OB
Radiology; 2001 Feb; 218(2):503-9. PubMed ID: 11161169
[TBL] [Abstract][Full Text] [Related]
7. Long-term follow-up of lobular neoplasia (atypical lobular hyperplasia/lobular carcinoma in situ) diagnosed on core needle biopsy.
Shah-Khan MG; Geiger XJ; Reynolds C; Jakub JW; Deperi ER; Glazebrook KN
Ann Surg Oncol; 2012 Oct; 19(10):3131-8. PubMed ID: 22847124
[TBL] [Abstract][Full Text] [Related]
8. Observation versus excision of lobular neoplasia on core needle biopsy of the breast.
Schmidt H; Arditi B; Wooster M; Weltz C; Margolies L; Bleiweiss I; Port E; Jaffer S
Breast Cancer Res Treat; 2018 Apr; 168(3):649-654. PubMed ID: 29299726
[TBL] [Abstract][Full Text] [Related]
9. Lobular in-situ neoplasia on breast core needle biopsy: imaging indication and pathologic extent can identify which patients require excisional biopsy.
Rendi MH; Dintzis SM; Lehman CD; Calhoun KE; Allison KH
Ann Surg Oncol; 2012 Mar; 19(3):914-21. PubMed ID: 21861212
[TBL] [Abstract][Full Text] [Related]
10. Management of Lobular Neoplasia Diagnosed by Core Biopsy.
Jani C; Lotz M; Keates S; Gupta Y; Walker A; Al Omari O; Parvez A; Patel D; Gnata M; Perry J; Khorashadi L; Weissmann L; Pories SE
Breast J; 2023; 2023():8185446. PubMed ID: 37114120
[TBL] [Abstract][Full Text] [Related]
11. Lobular carcinoma in situ or atypical lobular hyperplasia at core-needle biopsy: is excisional biopsy necessary?
Foster MC; Helvie MA; Gregory NE; Rebner M; Nees AV; Paramagul C
Radiology; 2004 Jun; 231(3):813-9. PubMed ID: 15105449
[TBL] [Abstract][Full Text] [Related]
12. Excisional biopsy should be performed if lobular carcinoma in situ is seen on needle core biopsy.
Shin SJ; Rosen PP
Arch Pathol Lab Med; 2002 Jun; 126(6):697-701. PubMed ID: 12033958
[TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance imaging-guided core needle breast biopsies resulting in high-risk histopathologic findings: upstage frequency and lesion characteristics.
Weinfurtner RJ; Patel B; Laronga C; Lee MC; Falcon SL; Mooney BP; Yue B; Drukteinis JS
Clin Breast Cancer; 2015 Jun; 15(3):234-9. PubMed ID: 25579460
[TBL] [Abstract][Full Text] [Related]
14. Atypical lobular hyperplasia and lobular carcinoma in situ at core needle biopsy of the breast: An incidental finding or are there characteristic imaging findings?
Amos B; Chetlen A; Williams N
Breast Dis; 2016 Jan; 36(1):5-14. PubMed ID: 27177338
[TBL] [Abstract][Full Text] [Related]
15. Lobular neoplasia on core needle biopsy does not require excision.
Nagi CS; O'Donnell JE; Tismenetsky M; Bleiweiss IJ; Jaffer SM
Cancer; 2008 May; 112(10):2152-8. PubMed ID: 18348299
[TBL] [Abstract][Full Text] [Related]
16. Management of high-risk breast lesions diagnosed on core biopsies and experiences from prospective high-risk breast lesion conferences at an academic institution.
Li X; Ma Z; Styblo TM; Arciero CA; Wang H; Cohen MA
Breast Cancer Res Treat; 2021 Feb; 185(3):573-581. PubMed ID: 33068196
[TBL] [Abstract][Full Text] [Related]
17. Classic lobular carcinoma in situ and atypical lobular hyperplasia at percutaneous breast core biopsy: outcomes of prospective excision.
Murray MP; Luedtke C; Liberman L; Nehhozina T; Akram M; Brogi E
Cancer; 2013 Mar; 119(5):1073-9. PubMed ID: 23132235
[TBL] [Abstract][Full Text] [Related]
18. Evaluating the Rate of Upgrade to Invasive Breast Cancer and/or Ductal Carcinoma In Situ Following a Core Biopsy Diagnosis of Non-classic Lobular Carcinoma In Situ.
Nakhlis F; Harrison BT; Giess CS; Lester SC; Hughes KS; Coopey SB; King TA
Ann Surg Oncol; 2019 Jan; 26(1):55-61. PubMed ID: 30362065
[TBL] [Abstract][Full Text] [Related]
19. Core Breast Biopsies Showing Lobular Carcinoma In Situ Should Be Excised and Surveillance Is Reasonable for Atypical Lobular Hyperplasia.
Sen LQ; Berg WA; Hooley RJ; Carter GJ; Desouki MM; Sumkin JH
AJR Am J Roentgenol; 2016 Nov; 207(5):1132-1145. PubMed ID: 27532153
[TBL] [Abstract][Full Text] [Related]
20. Is excision biopsy of fibroadenomas based solely on size criteria warranted?
Neville G; Neill CO; Murphy R; Corrigan M; Redmond PH; Feeley L; Bennett MW; O'Connell F; Browne TJ
Breast J; 2018 Nov; 24(6):981-985. PubMed ID: 29802656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
